Erickson's study will attempt to determine if these treatments are effective in reducing the occurrence of EIPH and whether they have any direct effect on performance.EIPH and the use of adjunct bleeder medications are of great concern to the racing industry for the appropriate care of the racehorse. In its determination of appropriate race-day medications, the Racing Medication and Testing Consortium has cited adjunct bleeder medications for potential use, if efficacy can be proven. The AAEP's annual Racing Forum identified the use of adjunct bleeder medications as a priority need for investigation, thus initiating the AAEP Foundation's solicitation of research proposals on the subject."This grant is an excellent example of the equine industry cooperating to improve the health and welfare of the horse," said AAEP past president Dr. Larry R. Bramlage, DVM, MS, who coordinated the call for proposals. "The project was recruited by the AAEP Foundation through a competitive granting process, and the partnership in funding by the Grayson-Jockey Club Research Foundation and the Racing Medication and Testing Consortium is making this investigation possible."The three organizations are each contributing $25,000 to the study. The progress of the grant will be monitored by the Grayson-Jockey Club Research Foundation using its monitoring and completion assessment system.Erickson's study will run from March 1, 2006 through Feb. 28, 2007.
Most Popular Stories
- Haskin: Dr. Fager, Where Are You?
- Hialeah May Push for Thoroughbred License
- Mucho Macho Man to Race in 2014
- Online Stallion Season Auction Set for Iowa
- NYRA Budget Passes, But Not Without Debate
- Ramseys Ready for Claiming Crown
- And They're Off: Hollywood Park Farewell
- Minimum Stakes Purse to Increase at Aqueduct
- Butler Gets Five-Year Suspension
- Rosalind Heads Hollywood Starlet